SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 421 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,625,261 | +74.5% | 21,657 | +64.8% | 1.10% | +63.4% |
| Q2 2023 | $1,504,793 | +84.7% | 13,140 | +122.3% | 0.67% | +71.4% |
| Q1 2023 | $814,713 | -12.0% | 5,911 | +2.4% | 0.39% | -44.8% |
| Q2 2020 | $926,000 | +202.6% | 5,774 | +84.5% | 0.71% | +91.4% |
| Q1 2020 | $306,000 | +23.4% | 3,129 | +91.5% | 0.37% | +136.3% |
| Q2 2019 | $248,000 | -39.8% | 1,634 | -52.7% | 0.16% | -51.4% |
| Q1 2019 | $412,000 | +82.3% | 3,454 | +67.0% | 0.32% | +85.6% |
| Q4 2018 | $226,000 | -17.2% | 2,068 | +22.4% | 0.17% | -26.6% |
| Q3 2018 | $273,000 | -53.0% | 1,689 | -78.5% | 0.24% | -46.0% |
| Q1 2018 | $581,000 | -47.8% | 7,840 | -60.8% | 0.44% | -35.0% |
| Q4 2017 | $1,112,000 | – | 19,982 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |